Generics - Rest of the World

Filter

Current filters:

Rest of the World

Popular Filters

1 to 25 of 61 results

Dubai Investments sells 66% stake in Globalpharma to Sanofi

29-06-2014

Dubai Investments PJSC, the leading investment company listed on the Dubai financial market [DFM], has…

GenericsGlobalpharmaMergers & AcquisitionsRest of the WorldSanofi

Recordati finalizes second tranche of Opalia Pharma acquisition

27-05-2014

Following previous announcements about its M&A activity, Italian drugmaker Recordati has now announced…

GenericsMergers & AcquisitionsOpalia PharmaRecordatiRest of the World

European generic drug makers sets out priorities for EU Trade Policy

European generic drug makers sets out priorities for EU Trade Policy

02-04-2014

European Generic Medicines Association (EGA) revealed this morning that its president, Nick Haggar, has…

EuropeGenericsPoliticsRegulationRest of the World

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Zimbabwe sees serious drug shortages, as NatPharm fails to meet demand

14-11-2013

A serious shortage of life-saving clinical drugs is having an adverse effect on the health sector in…

FinancialGenericsHealthcareRest of the World

Teva Pharma reaches $718 million tax settlement with Israel State

Teva Pharma reaches $718 million tax settlement with Israel State

12-11-2013

Israel-headquartered global generic drug giant Teva Pharmaceutical Industries has reached an agreement…

FinancialGenericsRest of the WorldTeva Pharmaceutical Industries

Abraaj sells stake in Opalia Pharma to Recordati

05-11-2013

The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

Teva results report increase in sales despite flat generic revenues

Teva results report increase in sales despite flat generic revenues

01-11-2013

Still shaken by the sudden resignation of its chief executive this week, Israel-based Teva Pharmaceutical…

FinancialGenericsRest of the WorldTeva Pharmaceutical Industries

“Generics, Get the Facts Straight” - subject of South Africa workshop

“Generics, Get the Facts Straight” - subject of South Africa workshop

29-10-2013

South Africa’s National Association of Pharmaceutical Manufacturers (NAPM) held a workshop for health…

GenericsPricingRegulationRest of the WorldSouth Africa

Increased use of generic drugs in South Africa could save health sector 400 million rand

Increased use of generic drugs in South Africa could save health sector 400 million rand

02-10-2013

In South Africa, a switch of 5% of the volume of branded medicines to a generic equivalent could save…

FinancialGenericsHealthcareMarkets & MarketingRest of the WorldSouth Africa

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

Promising outcome of EU platform on access to medicines in Africa

17-09-2013

The Platform on Access to Medicines in Developing Countries with a Focus on Africa took a step forward…

EuropeFinancialGenericsHealthcarePharmaceuticalRest of the World

Proposed Bill for South Africa Health Products Regulatory Authority

15-08-2013

The South African Minister of Health has published the proposed amendments to the Medicines and Related…

GenericsPharmaceuticalRegulationRest of the World

Campaign group's concern at blocks on India's generic exports

30-07-2013

An HIV and AIDS campaigner has written an open letter to the US government in protest at what it calls…

Anti-viralsBayerGenericsHealthcareNatco PharmaRest of the WorldSorafenib

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Greater generic drug penetration could reduce private health care cost in South Africa

18-07-2013

Recently, two of the larger hospital groups in South Africa, Netcare and Mediclinic, called for the Competition…

FinancialGenericsHealthcareMarkets & MarketingRest of the World

Less than 30% of drugs in Nigeria made locally

15-07-2013

Last week, the Director General, of Nigeria's National Agency for Foods, Drugs Administration and Control,…

GenericsMarkets & MarketingPharmaceuticalProductionRest of the World

Switzerland's Lonza involvement in South Africa pharma project in doubt

28-05-2013

The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

Brazilian pharma exports to GCC up 73% to reach over $7.4 million in 2012

13-05-2013

Brazil exported $7.48 million worth of pharmaceutical products to the Gulf Cooperation Council (GCC)…

GenericsMarkets & MarketingPharmaceuticalRest of the WorldSouth America

Africa's pharmaceutical industry faces numerous challenges, VoA reports

13-05-2013

Providing Africans with affordable health care could be realized if pharmaceutical products were produced…

Asia-PacificGenericsHealthcarePharmaceuticalProductionRest of the World

Experts to examine opportunities in growing African pharmaceutical market

12-03-2013

"At a time when growth in traditional pharmaceutical markets is stalling, strong macroeconomic fundamentals…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Anti-infective market in sub-Saharan Africa set to reach $377 million in 2018

05-03-2013

The high incidence of infectious diseases in sub-Saharan Africa is expected to sustain the demand for…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalRest of the World

Mylan debuts HIV/AIDS drug portfolio in South Africa

24-02-2013

US generics company Mylan (Nasdaq: MYL) says that its subsidiary in South Africa has launched a comprehensive…

Anti-viralsGenericsMarkets & MarketingMylan LaboratoriesRest of the World

1 to 25 of 61 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top